Prescribing for the Elderly Part I: Sensitivity of the Elderly to Adverse Drug Reactions*
1988; Wiley; Volume: 36; Issue: 2 Linguagem: Inglês
10.1111/j.1532-5415.1988.tb01785.x
ISSN1532-5415
Autores Tópico(s)Pharmaceutical studies and practices
ResumoJournal of the American Geriatrics SocietyVolume 36, Issue 2 p. 142-149 Prescribing for the Elderly Part I: Sensitivity of the Elderly to Adverse Drug Reactions* Lisa Nolan BS (Pharm), MS, Lisa Nolan BS (Pharm), MS Department of Clinical Pharmacology, The Royal College of Surgeons in Ireland, Dublin, Ireland.Search for more papers by this authorKevin O'Malley MD, PhD, Corresponding Author Kevin O'Malley MD, PhD Department of Clinical Pharmacology, The Royal College of Surgeons in Ireland, Dublin, Ireland.Department of Clinical Pharmacology, The Royal College of Surgeons in Ireland, St Stephen's Green, Dublin 2, Republic of Ireland.Search for more papers by this author Lisa Nolan BS (Pharm), MS, Lisa Nolan BS (Pharm), MS Department of Clinical Pharmacology, The Royal College of Surgeons in Ireland, Dublin, Ireland.Search for more papers by this authorKevin O'Malley MD, PhD, Corresponding Author Kevin O'Malley MD, PhD Department of Clinical Pharmacology, The Royal College of Surgeons in Ireland, Dublin, Ireland.Department of Clinical Pharmacology, The Royal College of Surgeons in Ireland, St Stephen's Green, Dublin 2, Republic of Ireland.Search for more papers by this author First published: February 1988 https://doi.org/10.1111/j.1532-5415.1988.tb01785.xCitations: 231 † Part II will appear in the March 1988 issue of the Journal of the American Geriatrics Society. ‡ This work was conducted with the generous support of the Medical Research Council of Ireland and the Royal College of Surgeons in Ireland. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Jick H: Drugs — remarkably nontoxic. N Engl J Med 291: 824, 1974. 2 Barr DP: Hazards of modern diagnosis and therapy —the price we pay. JAMA 129: 1452, 1955. 3 Melmon K: Preventable drug reactions, causes and cures. N Engl J Med 284: 1361, 1971. 4 Campbell WH, Johnson RE, Senft RA, et al: Treated adverse effects of drugs in an ambulatory population. Med Care 15: 599, 1977. 5 Mulroy R: Iatrogenic disease in general practice. Br Med J 2: 407, 1973. 6 Lamy PP: New dimensions and opportunities. Drug In-tell Clin Pharm 19: 399, 1985. 7 Report of the Royal College of Physicians: Medication for the elderly. J R Coll Physicians Lond 18: 7, 1984. 8 Bender AD: Drug sensitivity in the elderly, in J Crooks, IH Stevenson (eds): Drugs and the elderly. Oxford, The Macmillan Press, 1979, p 147. 9 Greenblatt DJ, Sellers EM, Shader RI: Drug disposition in old age. N Engl J Med 306: 1081, 1982. 10 Seidl CG, Thornton GF, Smith JW, et al: Studies on the epidemiology of adverse drug reactions: III. Reactions in patients on a general medical service. Bull John Hopkins Hosp 119: 299, 1966. 11 Hurwitz N: Predisposing factors in adverse reactions to drugs. Br Med J 1: 536, 1969. 12 Smidt WA, McQueen EG: Adverse reactions to drugs: a comprehensive inpatient survey. NZ Med J 76: 397, 1972. 13 Klein U, Klein M, Sturm H, Rothenbuhler M, et al: The frequency of adverse drug reactions as dependent upon age, sex and duration of hospitalization. Int J Clin Pharmacol 13: 187–195, 1976. 14 Levy M, Kletter-Hemo D, Nir I, et al: Drug utilization and adverse drug reactions in medical patients. Comparison of two periods 1969–1972 and 1973–1976. Isr J Med Sci 13: 1065, 1977. 15 Bottiger LE, Furhoff AK, Holmberg L: Drug induced blood dyscrasias. Acta Med Scand 205: 457, 1979. 16 Bottiger LE, Furhoff AK, Holmberg L: Fatal reactions to drugs. Acta Med Scand 205: 451, 1979. 17 Hutchinson TA, Flegel KM, Kramer MS, et al: Frequency, severity and risk factors for adverse reactions in adult outpatients: A prospective study. J Chron Dis 39: 533, 1986. 18 Bennett BS, Lipman AG: Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions. Am J Hosp Pharm 34: 931, 1977. 19 Hoddinott BC, Gowdey LW, Coulter WK, et al: Drug reactions and errors in administration on a medical ward. Can Med Assoc J 97: 1001, 1967. 20 Bergman HG, Aoki VS, Black HJ, et al: A new role for the pharmacist in the detection and evaluation of adverse drug reactions. Am J Hosp Pharm 28: 343, 1971. 21 Ogilvie RI, Ruedy J: Adverse drug reactions during hospitalisation. Can Med Assoc J 97: 1450, 1967. 22 Smith JW, Seidl LG, Cluff LE: Studies on the epidemiology of adverse drug reactions. Ann Int Med 65: 629, 1966. 23 Vakil BJ, Kulkarni RD, Chabria NL, et al: Intense surveillance of adverse drug reactions. J Clin Pharmacol 15: 435, 1975. 24 Kellaway GSM, McCrae E: Intensive monitoring of adverse drug effects in patients discharged from acute medical wards. N Z Med J 78: 525, 1973. 25 Klein LE, German PS, Levine DM, et al: Medication problems among outpatients. A study with emphasis on the elderly. Arch Int Med 144: 1185, 1984. 26 Schimmel EM: The hazards of hospitalization. Ann Int Med 60: 100, 1964. 27 Cluff LE, Thornton G, Seidl L, et al: Epidemiological study of adverse drug reactions. Trans Assoc Am Physicians 78: 255, 1965. 28 Sidel VW, Koch-Weser J, Barnett O, et al: Drug utilization and adverse reactions in a general hospital. JAMA 141: 80, 1967. 29 Slone D. Gaetano LF, Lipironte L, et al: Computer analysis of epidemiological data on effect of drugs on hospital patients. Pub Health Rep 84: 39, 1969. 30 Gardner P, Watson LJ: Adverse drug reactions: A pharmacist-based monitoring system. Clin Pharmacol Ther 11: 802, 1970. 31 Gray TK, Adams LL, Fallon HJ: Short-term intense surveillance of adverse drug reactions. J Clin Pharmacol 13: 61, 1973. 32 May FE, Stewart RB, Cluff LE: Drug interactions and multiple drug administration. Clin Pharmacol Ther 22: 322, 1977. 33 George CF, Kingscombe PM: Can adverse drug reactions be prevented? Adverse Drug Reactions Bull 80: 288, 1980. 34 Steel K, Gertman PM, Crescenzi C, et al: Iatrogenic illness on a general medical service at a university hospital. N Eng J Med 304: 638, 1981. 35 Wang RI, Terry LC: Adverse drug reactions in a Veterans Administration hospital. J Clin Pharmacol 11: 14, 1971. 36 Lumley LE, Walker SR, Hall CG, et al: The underreporting of adverse drug reactions seen in general practice. Pharmaceut Med 1: 205, 1986. 37 Meleny HE, Fraser ML et al: A retrospective study of drug usage and adverse drug reactions in hospital outpatients: Final report. Drug Inf Bull 2: 124, 1969. 38 Campbell WH, Johnson RE, Senft RA, et al: Adverse drug reactions in a disadvantaged population. J Community Health 3: 205, 1978. 39 Martys CR: Adverse reactions to drugs in general practice. Br Med J 2: 1194, 1979. 40 Stewart RB, Cluff LE: Studies on the epidemiology of adverse drug reactions: VI. Utilization and interactions of prescription and nonprescription drugs in outpatients. John Hopkins Med J 129: 319, 1971. 41 Hurwitz N: Admissions to hospitals due to drugs. Br Med J 1: 539, 1969. 42 Caranosos CJ, Stewart RB, Cluff LE: Drug-induced illness leading to hospitalization. JAMA 228: 713, 1974. 43 Miller RR: Hospital admissions due to adverse drug reactions. Arch Int Med 134: 219, 1974. 44 Mc Kenney JM, Harrison WL: Drug-related hospital admissions. Am J Hosp Pharm 33: 792, 1976. 45 Levy M, Lipshitz W, Eliakim M: Hospital admissions due to adverse drug reactions. Am J Med Sci 227: 49, 1979. 46 Levy M, Kewitz H, Altwein W, et al: Hospital admissions due to drug reactions: A comparative study from Jerusalem and Berlin. Eur J Clin Pharmacol 17: 25, 1980. 47 Cooke DI, van der Mevwe W, Pudifin DJ: Hospital admissions for adverse reactions to drugs and deliberate self-poisoning. South Afr Med J 67: 770, 1985. 48 Williamson J, Chopin JM: Adverse reactions to prescribed drugs in the elderly: A multicentre investigation. Age Ageing 9: 73, 1980. 49 Hurwitz N, Wade OL: Intensive hospital monitoring of adverse reactions to drugs. Br Med J 1: 531, 1969. 50 Sotaniemi E, Palva IP: The use of polypharmaceutical drug therapy in a medical ward. Ann Clin Res 4: 158, 1972. 51 Boethius G: Recording of drug prescriptions in the county of Jamtland, Sweden: Pattern of drug usage in 16600 individuals during 1970–75. Acta Med Scand 202: 241, 1977. 52 Lamy PP, Lesko LJ: Altered drug action in the elderly in Aller (ed): Annual reports in medicinal chemistry. Academic Press, 1985, p 295. 53 Irey NS: Adverse drug reactions and death. A review of 827 cases. JAMA 236: 575, 1976. 54 Roberts RK, Wilkinson GR, Branch RA, et al: Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide. Gastroenterology 75: 479, 1978. 55 Kelly JG, McGarry K, O'Brien E, et al: Bioavailability of labetalol increases with age. Br J Clin Pharmacol 14: 304, 1982. 56 Cusack B, Horgan J, Kelly JG, et al: Digoxin in the elderly: Pharmacokinetic consequences of old age. Clin Pharmacol Ther 25: 772, 1979. 57 Redolfi A, Borgogelli E, Ladola E: Blood level of cimetidine in relation to age. Eur J Clin Pharmacol 15: 257, 1979. 58 Shader RI, Greenblatt DJ, Harmatz JS, et al: Absorption and distribution of chlordiazepoxide in young and elderly male volunteers. J Clin Pharmacol 17: 709, 1977. 59 Klotz U, Avant GR, Hoyumpa A, et al: The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest 55: 347, 1975. 60 O'Malley K, Stevenson IH, Ward C, et al: Determinants of anticoagulant control in patients receiving warfarin. Br J Clin Pharmacol 4: 309, 1977. 61 Shepherd AMM, Hewick DS, Moreland TA, et al: Age as a determinant of sensitivity to warfarin. Br J Clin Pharmacol 4: 315, 1977. 62 Cook PJ, Flanagan R, James IM: Diazepam tolerance: Effect of age, regular sedation and alcohol. Br Med J 289: 351, 1984. 63 Castleden CM, George CF, Marcer D, et al: Increased sensitivity to nitrazepam in old age. Br Med J 1: 10, 1977. 64 Vestal RE, Wood AJJ, Shand DG et al: Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 26: 181, 1979. 65 Dillon N, Chung S, Kelly J, et al: Age and beta-adrenoceptor-mediated function. Clin Pharmacol Ther 27: 769, 1980. 66 Cotter T, O'Malley K: Decreased neutrophil cyclic AMP response to isoprenaline stimulation in the elderly. Clin Sci 65: 155, 1983. 67 Greenblatt DJ, Allen MD: Toxicity of nitrazepam in the elderly: A report from the Boston Collaborative Drug Surveillance Program. Br J Clin Pharmacol 5: 407, 1978. 68 Boston Collaborative Drug Surveillance Program: Clinical depression of the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age. N Engl J Med 288: 277, 1973. 69 McGarry K, Laher M, Fitzgerald D, et al: Baroreflex function in elderly hypertensives. Hypertension 5: 763, 1983. 70 World Health Organization: International drug monitoring—the role of the hospital. Drug Intell Clin Pharm 4: 101, 1970. 71 Reidenberg MM, Lowenthal DT: Adverse nondrug reactions. N Engl J Med 279: 678, 1968. 72 Koch-Weser J, Sellers EM, Zacest R: The ambiguity of adverse drug reactions. Eur J Clin Pharmacol 11: 75, 1977. 73 Karch FE, Lasagna L: Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 21: 247, 1977. 74 Kramer MS, Leventhal JM, Hutchinson TA, et al: An algorithm for the operational assessment of adverse drug reactions. JAMA 242: 623, 1979. 75 Venulet J, Ciucci A, Bernecker GC: Standarized assessments of drug–adverse reaction associations — rationale and experience. Int J Clin Pharmacol Ther Toxicol 18: 381, 1980. 76 Naranjo LA, Busto U, Sellers EM, et al: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30: 239, 1982. 77 Girard M: Testing the methods of assessment for adverse drug reactions. Adverse Drug React Acute Poisoning Rev 4: 237, 1984. 78 Moussa MAA, Bayoumi A, Al-Khars AA, et al: Adverse drug reaction monitoring in Kuwait (1981–1984). J Clin Pharmacol 25: 176, 1985. 79 Klein LE, German PS, Levine DM: Adverse drug reactions among the elderly: A reassessment. J Am Geriatr Soc 29: 525, 1981. Citing Literature Volume36, Issue2February 1988Pages 142-149 ReferencesRelatedInformation
Referência(s)